Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now displays revision v3.5.4 and the previous revision v3.5.3 has been removed.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a site/version release rather than a modification to the underlying study information.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision label on the page updated from v3.5.0 to v3.5.2, reflecting a minor site update rather than changes to study content.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.5.0 has been added and v3.4.3 has been removed. This update does not modify the study details or page content.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check109 days agoChange DetectedRevision: v3.4.2 was added to the page, and the older operating-status notice (Revision: v3.4.1) was removed.SummaryDifference0.4%

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.